PDL BioPharma, Inc. Current Part of Taxes to Pay

Current Part of Taxes to Pay of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Part of Taxes to Pay growth rates and interactive chart.


Highlights and Quick Summary

  • Current Part of Taxes to Pay for the quarter ending December 30, 2019 was $17 Thousand (a 0.0% decrease compared to previous quarter)
  • Year-over-year quarterly Current Part of Taxes to Pay decreased by -19.05%
  • Annual Current Part of Taxes to Pay for 2019 was $17 Thousand (a 6.25% increase from previous year)
  • Annual Current Part of Taxes to Pay for 2018 was $16 Thousand (a -98.84% decrease from previous year)
  • Annual Current Part of Taxes to Pay for 2017 was $1.38 Million (a -70.84% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Part of Taxes to Pay of PDL BioPharma, Inc.

Most recent Current Part of Taxes to Payof PDLI including historical data for past 10 years.

Interactive Chart of Current Part of Taxes to Pay of PDL BioPharma, Inc.

PDL BioPharma, Inc. Current Part of Taxes to Pay for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $0.02 $0.02 $0.03 $0.02 $0.02
2018 $0.02 $0.09 $0.22 $0.87 $0.02
2017 $1.38 $7.16 $15.0 $9.31 $1.38
2016 $4.72 $5.79 $9.79 $21.02 $4.72
2015 $3.37 $3.37
2014 $3.29 $6.49 $10.82 $5.34 $3.29
2013 $3.23 $18.75
2012 $18.59
2011 $12.58
2010 $24.47

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.